AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when...
In the wake of the COVID-19 pandemic and the associated development of a vaccine in record time, the biopharmaceutical industry has seen significant change. Today, we know that faster development is possible, though it is still challenging. That has increased the...
In the last few years, life sciences innovation has jumped by leaps and bounds. Many of the emerging autologous, patient-specific therapies being released are accomplishing things the general public never thought would be possible. These autologous treatments are...
Continuous manufacturing was a game-changer for the ability to deliver life-improving and life-saving biopharmaceutical treatments to patients as quickly as possible. Automation made it possible to make manufacturing significantly more efficient, helping teams to...
There exists an interesting tension in the life sciences industry; while people have access to more treatments for more maladies than at any other time in human history, there is also increasing pressure to deliver new, innovative treatments. For evidence, simply look...
It’s hard to discuss the life sciences today without talking about advanced therapeutics and personalized medicine. We are currently in a period of massive innovation that will reshape the delivery of medicine for decades to come. Where once pharmaceutical companies...
Bob Lenich joins podcast host Jim Cahill to discuss how the Process Knowledge Management (PKM) digital collaboration platform can help streamline the process and minimize errors, resulting in faster time-to-market for pharmaceutical & biopharmaceutical manufacturers.
In the life sciences, bringing treatments to market quicker is no longer a bonus. Today, accelerating the treatment development pipeline is an expectation—arguably a core value—of the world’s most respected pharmaceutical companies. The pipeline for the COVID vaccine...
There’s no question that today’s life sciences landscape is changing dramatically. As new personalized medicine solutions emerge, companies are rapidly changing scale to include more multi-product manufacturing facilities. Many of these facilities are manufacturing...
Recently, as cell and gene therapies have begun to emerge in the life sciences manufacturing landscape, an important concept has begun to draw attention: traceability. However, it is important to remember that traceability was critical long before today’s most...
It can be hard to keep up with the many rapid changes occurring in the life sciences industry these days. In an effort to embrace improved speed to market, sustainability, and quality, life sciences manufacturers are employing a wide range of software and technologies...
People are more aware than ever of the many amazing ways new treatments can improve their lives. As a result, life sciences companies are under more pressure than ever to safely deliver new, innovative treatments to market to satisfy customer demand. The key to...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.